Regulated Information

Period

recent search

Reset

Showing: 1 – 05 of 167 Regulated Information

Ipsen to acquire Epizyme, expanding its portfolio in oncology
27 June 2022

27 June 2022

Download Ipsen to acquire Epizyme, expanding its portfolio in oncology
Ipsen to acquire Epizyme, expanding its portfolio in oncology

PARIS, FRANCE & CAMBRIDGE, MASSACHUSETTS, 27 June 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) and Epizyme (Nasdaq: EPZM) today announced that they have entered into a definitive merger agreement under which Ipsen will acquire Epizyme. The transaction was unanimously approved by…


Share buyback program – Ipsen reporting from 13 june to 17 June 2022 – Detailed
21 June 2022

21 June 2022

Download Share buyback program – Ipsen reporting from 13 june to 17 June 2022 – Detailed
Share buyback program – Ipsen reporting from 13 june to 17 June 2022 – Detailed

This article or press release has no online content. Please download the associated documents for more information.


Share buyback program – Ipsen reporting from 06 june to 10 June 2022 – Detailed
14 June 2022

14 June 2022

Download Share buyback program – Ipsen reporting from 06 june to 10 June 2022 – Detailed
Share buyback program – Ipsen reporting from 06 june to 10 June 2022 – Detailed

This article or press release has no online content. Please download the associated documents for more information.


Ipsen initiates a share buy-back program to cover its employee free share-allocation plan
01 June 2022

01 June 2022

Download Ipsen initiates a share buy-back program to cover its employee free share-allocation plan
Ipsen initiates a share buy-back program to cover its employee free share-allocation plan

This article or press release has no online content. Please download the associated documents for more information.



1 … 27 28 29 30 31 32 33 34